Sign In
Buy JJSF
$75.77
-0.360 (-0.473%)
At Close: Jun 03, 2026
J&J kicks off final study of single-shot COVID-19 vaccine in 60,000 volunteers
01:22pm, Wednesday, 23'rd Sep 2020Johnson & Johnson’s Covid-19 vaccine starts large-scale human trials
12:56pm, Wednesday, 23'rd Sep 2020
Four experimental coronavirus shots have now entered Phase 3 testing in the U.S.
Johnson & Johnson kicks off final study of single-shot COVID-19 vaccine in 60,000 volunteers
12:32pm, Wednesday, 23'rd Sep 2020
The pharmaceutical company expects results of the Phase III trial by year end or early next year
Late-stage study of first single-shot vaccine begins in US
12:21pm, Wednesday, 23'rd Sep 2020
Johnson & Johnson is beginning a huge final-stage study to try to prove if a single-dose COVID-19 vaccine can protect against the virus
J&J mulai uji akhir vaksin corona dosis tunggal dengan 60.000 relawan
12:12pm, Wednesday, 23'rd Sep 2020
Perusahaan Johnson & Johnson (J&J) asal Amerika Serikat (AS) pada Rabu memulai uji akhir vaksin COVID-19 satu suntikan dengan 60.000 ...
5 things to know before the stock market opens Wednesday
11:44am, Wednesday, 23'rd Sep 2020
Dow futures pointed to a gain at Wednesday's open, one day after the 30-stock benchmark broke a three-session losing streak.
J&J launches first phase 3 trial of single-dose Covid-19 vaccine
11:41am, Wednesday, 23'rd Sep 2020
Trial will recruit 60,000 across three continents
Covid-19 vaccine: Johnson & Johnson starts massive global phase 3 clinical trial
11:36am, Wednesday, 23'rd Sep 2020
Johnson & Johnson's global trials of its single-dose Covid-19 vaccine will enrol up to 60,000 volunteers.The dosing up marks the first big US trial of an inoculation that may work after just one shot
Johnson & Johnson begins giant trial testing of single dose Covid-19 vaccine
11:19am, Wednesday, 23'rd Sep 2020
WASHINGTON (BLOOMBERG) - Johnson & Johnson has begun dosing up to 60,000 volunteers in a study of its Covid-19 vaccine, marking the first big US trial of an inoculation that may work after just one sh
Late-stage study of first single-shot vaccine begins in US
11:09am, Wednesday, 23'rd Sep 2020
Johnson & Johnson is beginning a huge final-stage study to try to prove if a single-dose COVID-19 vaccine can protect against the virus
Johnson & Johnson Begins Final-Stage Testing of Covid-19 Vaccine | MarketScreener
11:00am, Wednesday, 23'rd Sep 2020Johnson & Johnson's stock rallies after Phase 3 trial launched for COVID-19 vaccine candidate
10:56am, Wednesday, 23'rd Sep 2020
Shares of Johnson & Johnson undefined rallied 2.2% in premarket trading Wednesday, after the health care and pharmaceutical company said it launched its...
Major study to start for COVID-19 vaccine developed by Johnson & Johnson, Beth Israel - The Boston Globe
10:51am, Wednesday, 23'rd Sep 2020
Up to 60,000 volunteers, including some in Boston, will take part in the trial following encouraging data from more limited testing.
J&J enters Phase III of clinical trial for its one-shot COVID vaccine
10:49am, Wednesday, 23'rd Sep 2020
On Wednesday. Johnson & Johnson entered Phase III of clinical trials for its experimental coronavirus vaccine, which does not need to be frozen and may require just one dose instead of two.
